|
Post by otherottawaguy on Feb 25, 2015 17:29:46 GMT -5
Settlement Date
| Short Interest
| Avg Daily Share Volume
| Days To Cover
| % of Float (406M)
| % of non-Mann Float (206M)
| % non Mann, non institutional (105M)
| 2/13/2015
| 86,114,829
| 9,260,731
| 9.298923
| 21.2%
| 41.8%
| 82.0%
| 1/30/2015
| 80,678,801
| 4,863,394
| 16.588991
| 19.9%
| 39.2%
| 76.8%
| 1/15/2015
| 76,855,662
| 4,475,961
| 17.170762
| 19.6%
| 37.3%
| 73.2%
| 12/31/2014
| 75,654,134
| 4,169,132
| 18.146255
| 18.6
| 36.7%
| 72.0%
|
This table does not take into account any hedge strategies, options fandangles or convertible bonds.
It also negates the 9M B0fA shares due to be returned to treasury that are in the current short interest calculation.
It may be safe to consider with the Warrants and convertibles that there are closer to 450M out, but that the percentage of ownership by Dr. Mann, Institutions and shorts remains approximately the same percentage.
Enjoy,
OOG
|
|
|
Post by otherottawaguy on Feb 25, 2015 13:48:01 GMT -5
Waiting to see a drop of 9M during the August period. Hope it about $15 a share when we do so that BofA feels some pain.
OOG
|
|
|
Post by otherottawaguy on Feb 25, 2015 9:27:04 GMT -5
Did we learn anything?
I could hardly follow what MNKD was saying let alone what the question was that was being asked.
OOG
|
|
|
Post by otherottawaguy on Feb 25, 2015 9:25:11 GMT -5
Just received this from Griffin:
GRIFFIN SECURITIES Member FINRA, SIPC Keith A. Markey, Ph.D., M.B.A. Stock Symbol NASDAQ: MNKD Current Price $6.72 12 mos. Target Price $16.25 Market Cap $2,726.3 mln
MannKind Corp. BUY Company Update : Pharmaceuticals
Afrezza Debuts & Strategic Plans Emerge
MannKind and Sanofi are preparing for growing demand for Afrezza®. It’s still too early to get a read on uptake of the inhalable insulin, since it’s been on the market for little more than two weeks. We believe the initial demand is coming from diabetics who participated in the clinical trials and others who became aware of the drug’s unique attributes well before launch. By mid-year, sales should benefit from the marketing support, a larger dosage strength should be available, and favorable reimbursement policies should be in place. In preparation, MannKind is adding fill & finish production lines that will more than triple its production capacity in the June quarter.
The R&D pipeline will be refilled soon. MannKind plans to develop Technosphere® formulations of active pharmaceutical ingredients in three areas: pulmonary disease, pain, and cancer supportive care. The compounds will have a minimal development time, since they are already approved in other formulations. Also, the Company is targeting large markets in which a Technosphere preparation will offer a new approach to medicating. The first such product may launch in late 2016.
Operations performed in line with expectations to close out an eventful year. MannKind received $200 million via an upfront fee and two $25 million milestone payments, but no revenues were booked in the quarter. The accounting treatment for these payments and the Company’s share of the losses incurred by the partners in the early stages of Afrezza’s commercialization is somewhat unusual, as we discuss in this report. Otherwise, the quarterly results showed good control over R&D and general & administrative expenses. Operating costs should remain at levels comparable to or lower than those of the December quarter in the months ahead. We are looking for Afrezza to begin generating a profit for MannKind in 2016.
The Company will probably refinance debt that is coming due in August. The $100 million convertible debt has a conversion price of $6.80 a share, which is within reach. However, we believe MannKind would prefer to refinance, given today’s low interest rate environment and the opportunity to avoid diluting shareholders.
Our revised financial model points to a bright future. We continue to give MNKD stock a BUY rating and a 12-month price target of $16.25.
|
|
|
Post by otherottawaguy on Feb 24, 2015 18:21:29 GMT -5
If technosphere has the potential that they are always reiterating, I for one, do not want to see a buyout. No real way of valuing the company.
OG
|
|
|
Post by otherottawaguy on Feb 24, 2015 17:54:31 GMT -5
I would like to receive my pony per share from a ranch in Maranello. Multiple ponies can be bunch into groups. Partial to Red ones.
OOG
|
|
|
Post by otherottawaguy on Feb 24, 2015 16:18:25 GMT -5
Sam must be independently wealthy or very far along the 12 steps at Gamblers Anonymous to not be joining in the fun.
Wish him the best,
OOG
|
|
|
Post by otherottawaguy on Feb 24, 2015 16:08:41 GMT -5
Got a question for the group as well.
If MNKD is paying for trials of a "Soon to be off patent drug", could MNKD not market the product along with Sanofi and just bypass the former patent holder? Cards would really be in MNKD hands at that point.
OOG
|
|
|
Post by otherottawaguy on Feb 24, 2015 10:49:20 GMT -5
Anyone been to Schwatzs in Montreal on St Laurent? Usually have to line up to get in, no matter what time of the day/night it is. www.schwartzsdeli.com/OOG
|
|
|
Post by otherottawaguy on Feb 20, 2015 9:52:15 GMT -5
Adumb Fartstain, is anyone still reading his tripe? Sent that lad and what he has to back to the minors, heard he even got cut from the farm team.
Heard a good comment this week about his educational background.
The only question a Poli Sci major is qualified to answer is: "How did it feel to move back into your parents basement after graduating?"
But one that they are qualified to ask is: "Will that be fires with that, sir?"
Sorry if I offended anybody, so just to self deprecate, remember that I went to Carleton, where the "K" stands for Quality...
Laughed I did, hope you are too,
OOG
|
|
|
Post by otherottawaguy on Feb 20, 2015 8:22:03 GMT -5
------------ Post Script: Screw this -18 degree / -35 degree windchill weather in Minnesota. I think I'm moving to Idaho. Guess we won't be seeing you here in Ottawa then. -28 with -44 windchill.
Suck it up buttercup... (this is me smiling with my balaclava on).
OOG
|
|
|
Post by otherottawaguy on Feb 18, 2015 16:33:09 GMT -5
2 million shares with 1.5M at the ask in 10 min has that kind of effect I would guess... ;-)
|
|
|
Post by otherottawaguy on Feb 18, 2015 13:49:41 GMT -5
Tried to get him over here by providing a ddoouubbllee typed link to fool the YMB censor script.
Anyone know if he/she found their way here?
OOG
|
|
|
Post by otherottawaguy on Feb 17, 2015 15:33:15 GMT -5
The odds of TD, RBC, Bank of NovaScotia going belly up are about zero. Just wished there was a way to lend shares it this theoretically capitalist country called Canada... Again anyone know of any way of doing this in Canada? Tried BMO last week and they said that there were no programs in place to "Lend" shares by specific holders of those share. They told me that if you had purchases on margin, they would be more than glad to lend them out for you, but alas would not be willing to share any of the revenues generated. Told me that they charged those that borrowed a level of interest comparable to what you are paying on your margin amounts.
Guy I was talking to sounded interested in passing up the info for discussion, but will probably not effect the status quo.
OOG
|
|
|
Post by otherottawaguy on Feb 17, 2015 10:33:30 GMT -5
I hear Greece might be up for grabs in the near future...
|
|